ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,862 Cr | ₹6,810 Cr | ₹3,472 Cr | ₹2,113 Cr | ₹1,703 Cr |
What is the latest Total Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹6,862 Cr |
| Mar2024 | ₹6,810 Cr |
| Mar2023 | ₹3,472 Cr |
| Mar2022 | ₹2,113 Cr |
| Mar2021 | ₹1,703 Cr |
How is Total Liabilities of ERIS LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,862 Cr | 0.76 | |
| Mar2024 | ₹6,810 Cr | 96.16 | |
| Mar2023 | ₹3,472 Cr | 64.33 | |
| Mar2022 | ₹2,113 Cr | 24.07 | |
| Mar2021 | ₹1,703 Cr | - | |
Compare Total Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹19,971.0 Cr | 7.4% | -5.8% | 17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 7.4% |
-5.8% |
17.4% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses